Tanawin Nopsopon

830 total citations
44 papers, 430 citations indexed

About

Tanawin Nopsopon is a scholar working on Infectious Diseases, Physiology and Nephrology. According to data from OpenAlex, Tanawin Nopsopon has authored 44 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Physiology and 9 papers in Nephrology. Recurrent topics in Tanawin Nopsopon's work include Asthma and respiratory diseases (10 papers), COVID-19 Clinical Research Studies (8 papers) and Dialysis and Renal Disease Management (7 papers). Tanawin Nopsopon is often cited by papers focused on Asthma and respiratory diseases (10 papers), COVID-19 Clinical Research Studies (8 papers) and Dialysis and Renal Disease Management (7 papers). Tanawin Nopsopon collaborates with scholars based in United States, Thailand and United Kingdom. Tanawin Nopsopon's co-authors include Krit Pongpirul, Thinley Dorji, Ayobami Akenroye, Ming‐Li Chen, Nattiya Hirankarn, Sasitorn Siritho, Talerngsak Kanjanabuch, Corinne Keet, Hwanhee Hong and G. Caleb Alexander and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Tanawin Nopsopon

38 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanawin Nopsopon United States 12 104 91 80 73 63 44 430
Anna Faura Spain 11 69 0.7× 53 0.6× 51 0.6× 33 0.5× 11 0.2× 26 389
Subhashini A. Sellers United States 6 136 1.3× 237 2.6× 17 0.2× 34 0.5× 14 0.2× 11 404
Rebecca Collins United States 9 66 0.6× 20 0.2× 22 0.3× 101 1.4× 21 0.3× 15 622
Siegfried Görg Germany 14 178 1.7× 106 1.2× 48 0.6× 32 0.4× 19 0.3× 30 557
Yi‐Hsuan Lee Taiwan 11 17 0.2× 63 0.7× 51 0.6× 43 0.6× 12 0.2× 48 352
Francisco Navarro Spain 11 43 0.4× 121 1.3× 36 0.5× 146 2.0× 40 0.6× 25 795
Héctor Alexander Velásquez García Canada 11 137 1.3× 81 0.9× 5 0.1× 27 0.4× 33 0.5× 43 325
Cuicui Dong China 8 186 1.8× 54 0.6× 8 0.1× 106 1.5× 18 0.3× 10 476
Cuiting Luo China 8 365 3.5× 71 0.8× 11 0.1× 82 1.1× 11 0.2× 18 575

Countries citing papers authored by Tanawin Nopsopon

Since Specialization
Citations

This map shows the geographic impact of Tanawin Nopsopon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanawin Nopsopon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanawin Nopsopon more than expected).

Fields of papers citing papers by Tanawin Nopsopon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanawin Nopsopon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanawin Nopsopon. The network helps show where Tanawin Nopsopon may publish in the future.

Co-authorship network of co-authors of Tanawin Nopsopon

This figure shows the co-authorship network connecting the top 25 collaborators of Tanawin Nopsopon. A scholar is included among the top collaborators of Tanawin Nopsopon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanawin Nopsopon. Tanawin Nopsopon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nopsopon, Tanawin, et al.. (2025). Patients with Higher Exacerbation Burden and Eosinophil Counts are More Likely to Require Multiple Biologics for Asthma Control. Journal of Asthma and Allergy. Volume 18. 1377–1383.
2.
Nopsopon, Tanawin, et al.. (2025). Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy. Medicina. 61(1). 62–62. 1 indexed citations
3.
Nopsopon, Tanawin, Qingwen Chen, Craig E. Wheelock, et al.. (2024). Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma. ERJ Open Research. 10(4). 931–2023. 2 indexed citations
4.
Nopsopon, Tanawin, et al.. (2024). Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics. Respiratory Medicine. 234. 107802–107802. 1 indexed citations
5.
Nopsopon, Tanawin, Guang‐Biao Zhou, Rong Hu, Corinne Keet, & Ayobami Akenroye. (2023). Comparative Effectiveness of Dupilumab and Omalizumab in Improving Exacerbations in Individuals With Allergic Asthma. A6650–A6650. 1 indexed citations
6.
Nopsopon, Tanawin, et al.. (2023). Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis. Frontiers in Oncology. 13. 1144021–1144021. 30 indexed citations
7.
Suputtitada, Areerat, Tanawin Nopsopon, Thanitsara Rittiphairoj, & Krit Pongpirul. (2023). Intra-Articular Facet Joint Injection of Normal Saline for Chronic Low Back Pain: A Systematic Review and Meta-Analysis. Preprints.org. 2 indexed citations
8.
9.
Kanjanabuch, Talerngsak, Tanawin Nopsopon, Krit Pongpirul, et al.. (2023). Exploring hospital practice types and their impact on glomerular pathologic patterns: Insights from the largest kidney biopsy cohort in Thailand. Nephrology. 28(S1). 24–34.
10.
Nopsopon, Tanawin, et al.. (2022). Nonoperative treatment for pain sensitization in patients with low back pain: protocol for a systematic review. Systematic Reviews. 11(1). 59–59. 2 indexed citations
11.
Nopsopon, Tanawin, et al.. (2022). Probiotic as a Potential Gut Microbiome Modifier for Stroke Treatment: A Systematic Scoping Review of In Vitro and In Vivo Studies. Nutrients. 14(17). 3661–3661. 12 indexed citations
12.
Nopsopon, Tanawin, et al.. (2022). Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: a prospective cohort study. The Lancet Regional Health - Southeast Asia. 8. 100106–100106. 8 indexed citations
13.
Nopsopon, Tanawin, et al.. (2022). Efficacy of Wang Nam Yen herbal tea on human milk production: A randomized controlled trial. PLoS ONE. 17(1). e0247637–e0247637. 4 indexed citations
14.
Prasithsirikul, Wisit, Tanawin Nopsopon, Phanupong Phutrakool, et al.. (2022). ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis. Vaccines. 10(6). 959–959. 3 indexed citations
15.
16.
17.
Nopsopon, Tanawin, et al.. (2021). Seroprevalence of hospital staff in a province with zero COVID-19 cases. PLoS ONE. 16(4). e0238088–e0238088. 18 indexed citations
18.
Nopsopon, Tanawin, et al.. (2021). Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis. PLoS neglected tropical diseases. 15(6). e0009156–e0009156. 19 indexed citations
19.
Nopsopon, Tanawin, et al.. (2021). COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study. BMJ Open. 11(10). e046676–e046676. 8 indexed citations
20.
Siritho, Sasitorn, Tanawin Nopsopon, & Krit Pongpirul. (2020). Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis. Journal of Neurology. 268(12). 4549–4562. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Faura Breakdown of academic impact, for papers by Subhashini A. Sellers Breakdown of academic impact, for papers by Rebecca Collins Breakdown of academic impact, for papers by Siegfried Görg Breakdown of academic impact, for papers by Yi‐Hsuan Lee Breakdown of academic impact, for papers by Francisco Navarro Breakdown of academic impact, for papers by Héctor Alexander Velásquez García Breakdown of academic impact, for papers by Cuicui Dong Breakdown of academic impact, for papers by Cuiting Luo
Rankless by CCL
2026